Amna Ali, Ph.D. - Publications
Affiliations: | 2014 | Mercer University, Macon, GA, United States |
Area:
Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Ali A, Burns TJ, Lucrezi JD, May SW, Green GR, Matesic DF. Amidation inhibitors 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester are novel HDAC inhibitors with anti-tumorigenic properties. Investigational New Drugs. 33: 827-34. PMID 26065689 DOI: 10.1007/S10637-015-0254-2 | 0.678 | |||
2015 | Burns TJ, Ali A, Matesic DF. Comparative effects of 4-phenyl-3-butenoic acid and vorinostat on cell growth and signaling. Anticancer Research. 35: 775-84. PMID 25667457 | 0.736 | |||
2015 | Ali A, Caggia S, Matesic DF, Khan SA. Abstract 2669: Chaetoglobosin K, an Akt pathway inhibitor, prevents proliferation and migration of prostate carcinoma cells Cancer Research. 75: 2669-2669. DOI: 10.1158/1538-7445.Am2015-2669 | 0.752 | |||
2014 | Ali A, Matesic DF. Abstract 4523: Chaetoglobosin K, a dual Akt and JNK inhibitor, modulates Akt phosphorylation in an mTORC2 independent manner Cancer Research. 74: 4523-4523. DOI: 10.1158/1538-7445.Am2014-4523 | 0.768 | |||
2013 | Matesic DF, Ali A, Sidorova TS, Burns TJ. A Cell-Cell Communication Marker for Identifying Targeted Tumor Therapies. Current Bioactive Compounds. 9: 255-262. PMID 25404879 DOI: 10.2174/157340720903140119155322 | 0.652 | |||
2013 | Ali A, Sidorova TS, Matesic DF. Dual modulation of JNK and Akt signaling pathways by chaetoglobosin K in human lung carcinoma and ras-transformed epithelial cells. Investigational New Drugs. 31: 525-34. PMID 23054210 DOI: 10.1007/S10637-012-9883-X | 0.653 | |||
2012 | Ali A, Matesic DF. Abstract 1810: Mechanistic studies of the dual Akt and JNK inhibitor Chaetoglobosin K: Effect on downstream pathways and AP-1 proteins in tumorigenic cells Cancer Research. 72: 1810-1810. DOI: 10.1158/1538-7445.Am2012-1810 | 0.765 | |||
Show low-probability matches. |